Enhancement of antigen-specific interleukin 2 production by adding liposomes to rabies antigens for priming.

[1]  P. Perrin,et al.  The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2. , 1987, Cellular immunology.

[2]  M. Bergdoll,et al.  Production of human and murine interleukin-2 by toxic shock syndrome toxin-1. , 1986, Immunology.

[3]  E. Celis,et al.  Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma. , 1986, Journal of immunology.

[4]  P. Perrin,et al.  Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies. , 1985, Vaccine.

[5]  R. Thorpe,et al.  Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes. , 1985, Immunology.

[6]  R. Lerner,et al.  T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. , 1984, Journal of immunology.

[7]  R. Robb.  Interleukin 2: the molecule and its function. , 1984, Immunology today.

[8]  P. Shek,et al.  Immune response mediated by liposome-associated protein antigens. I. Potentiation of the plaque-forming cell response. , 1982, Immunology.

[9]  N. Rooijen,et al.  Liposomes in immunology: Evidence that their adjuvant effect results from surface exposition of the antigens , 1980 .

[10]  D. Gerlier,et al.  Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa). , 1980, British Journal of Cancer.

[11]  N. Rooijen,et al.  Liposomes in immunology: the immune response against antigen-containing liposomes. , 1977 .